Live Breaking News & Updates on Walk Acquisition|Page 1

Stay updated with breaking news from Walk acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

eFFECTOR Therapeutics (NASDAQ:EFTR) Earns Buy Rating from JMP Securities

EFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating)‘s stock had its “buy” rating reiterated by equities research analysts at JMP Securities in a research report issued to clients and investors on Monday, TipRanks reports. They presently have a $8.00 target price on the stock. JMP Securities’ price target indicates a potential upside of 64.61% from the company’s […] ....

Thomson Reuter , Stifel Nicolaus , Christopherb Ehrlich , Effector Therapeutics Inc , Geode Capital Management , Securities Exchange Commission , Credit Suisse Group , Zacks Investment Research , Sectoral Asset Management Inc , Locust Walk Acquisition Corp , Citadel Advisors , Get Rating , Investment Research , Suisse Group , Director Christopher , Exchange Commission , Asset Management Inc , Capital Management , Street Group , Walk Acquisition , Effector Therapeutics , Nasdaq Eftr , Reiterated Rating , Jmp Securities ,

eFFECTOR Therapeutics (NASDAQ:EFTR) Announces Earnings Results, Beats Estimates By $0.68 EPS

EFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating) released its quarterly earnings results on Wednesday. The company reported $0.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.24) by $0.68, MarketWatch Earnings reports. NASDAQ:EFTR traded up $0.07 during mid-day trading on Thursday, hitting $4.14. The company’s stock had a trading volume […] ....

Thomson Reuter , Stifel Nicolaus , Christopherb Ehrlich , Northern Trust Corp , Effector Therapeutics Inc , Geode Capital Management , Securities Exchange Commission , Credit Suisse Group , Zacks Investment Research , Locust Walk Acquisition Corp , Citadel Advisors , Get Rating , Marketwatch Earnings , Suisse Group , Investment Research , Director Christopher , Exchange Commission , Capital Management , Street Group , Walk Acquisition , Effector Therapeutics , Nasdaq Eftr ,

"The Buzz" Show: Locust Walk Acquisition Corp. (NASDAQ: LWAC) Merger Approval

"The Buzz" Show: Locust Walk Acquisition Corp. (NASDAQ: LWAC) Merger Approval
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

Effector Therapeutics Inc , Locust Walk Acquisition Corp , Featuring Our Corporate News Recap , Walk Acquisition , Shares Skyrocket Upon Merger , Business Combination , Locust Walk Acquisition ,